The combination therapy showed a marked reduction in stress behaviors in animal models, indicating potential benefits for patients suffering from treatment-resistant depression. Eric Weisblum, CEO of ...
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
“We are encouraged by these results, which point to what we believe is a promising new approach for managing severe stress-related psychiatric disorders,” said Eric Weisblum, CEO of Silo Pharma. “In ...
Hosted on MSN12mon
Silo Pharma Collaborates With Medspray Pharma For Intranasal Technology For Stress Disorder CandidateSilo Pharma has obtained exclusive rights to its spray mist technology for use with multiple indications, including post-traumatic stress disorder (PTSD) and anxiety, as well as Alzheimer's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback